New York, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "MR Imaging in Neurosurgery Market - A Global and Regional Analysis: Focus on Types, Products, End User, and Region - Analysis and Forecast, 2022-2031" - https://www.reportlinker.com/p06317751/?utm_source=GNW
7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031. The market is driven by factors such as the increasing prevalence of neurological disorders requiring surgical intervention, rising preference for minimally invasive surgeries, growing demand for intraoperative imaging, and technological advancements in the field of robotics and medical imaging.
Market Lifecycle Stage
MR imaging market in neurosurgery is still in the development phase. Increased research and development activities are underway to develop more products.
The opportunity for growth of MR imaging market in neurosurgery lies in the development of cost-effective robotic-assisted MRI systems and the development of MRI-compatible robotic systems.
Impact of COVID-19
The COVID-19 pandemic led to the deferral of MRI performance in the imaging industry.The impact of COVID-19 on imaging facilities is ambiguous, as some imaging techniques such as X-Ray and CT were actively used, whereas MRI and ultrasound were of limited use during the pandemic.
Before the COVID-19 pandemic, MR imaging in neurosurgery was majorly undertaken in hospitals and clinical facilities. Owing to factors such as travel restrictions and the risk of transmission of the virus, there was a decrease in MR imaging in neurosurgery.
As the recovery phase of the COVID-19 pandemic begins, MR imaging in neurosurgery procedures is expected to normalize.
Market Segmentation:
Segmentation 1: by Types
• Conventional MR Imaging Devices
• Robotic-Assisted MR Imaging Devices
The global MR imaging market in neurosurgery (by type) is expected to be dominated by the conventional MR imaging devices segment.
Segmentation 2: by Products
• Systems
• Instruments and Accessories
The global MR imaging market in neurosurgery (by product) in the product segment is expected to be dominated by the systems segment.
Segmentation 3: by End User
• Hospitals
• Ambulatory Surgery Centers and Others
The global MR imaging market in neurosurgery (by end user) is dominated by the hospital segment.
Segmentation 4: by Region
• North America - U.S., Canada
• Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
• Rest-of-the-World- Japan, China, Rest-of-Rest-of-the-World
Recent Developments in Global MR Imaging Market in Neurosurgery
• In June 2022, Hyperfine Inc. announced its expansion into Australia and New Zealand with Medical Device Registration and notification.
• In June 2022, Hyperfine Inc. received FDA Clearance for its two new imaging sequences.
• In May 2022, Koninklijke Philips N.V. received FDA 510(k) clearance for its latest breakthrough high-performance MR 7700 system.
• In April 2022, FAULHABER integrated with a new subsidiary, named, PDT Präzisionsdrehteile GmbH from Nürtingen.
• In March 2022, AiM Medical Robotics raised $3.4 million in seed financing to advance neurosurgery with MRI-compatible robotics.
• In February 2022, Esaote S.p.A received FDA approval of the Magnifico Open MRI system.
Demand – Drivers and Limitations
Following are the drivers for MR imaging market in neurosurgery:
• Increasing Prevalence of Neurological Disorders Requiring Surgical Intervention
• Rising Preference for Minimally Invasive Surgeries
• Growing Demand for Intraoperative Imaging
• Technological Advancements in the Field of Robotics and Medical Imaging
The market is expected to face some limitations too due to the following challenges:
• High Cost of Investment in Robotic-Assisted MRI in Neurosurgeries
• Limitations of MRI
How Can This Report Add Value to an Organization?
Type: The type segment helps the reader understand the different types of MR imaging in neurosurgery types available in the market.Moreover, the study provides the reader with a detailed understanding of the different products (systems and instruments, and accessories).
Furthermore, the study also covers different segments of type (conventional MR imaging devices and robotic-assisted MR imaging devices).
Growth/Marketing Strategy: The global MR imaging market in neurosurgery has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture.The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market.
For instance, in June 2022, Hyperfine Inc. received FDA Clearance for its two new imaging sequences, and in November 2021, Medtronic plc partnered with Rune Labs to improve its understanding of neurostimulation with brain data.
Competitive Strategy: Key players in the global MR imaging market in neurosurgery analyzed and profiled in the study involve established and emerging players that offer different products for MR imaging in neurosurgery.Moreover, a detailed competitive benchmarking of the players operating in the global MR imaging market in neurosurgery has been done to help the reader understand how players stack against each other, presenting a clear market landscape.
Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent established names in this market are:
• AiM Medical Robotics
• Aspect Imaging Ltd.
• Brainlab AG
• Canon Inc.
• Deerfield Management
• Esaote S.p.A
• FAULHABER
• Fonar Corporation
• Fujifilm Holdings Corporation
• General Electric Company
• Hyperfine Inc.
• Insightec
• Koninklijke Philips N.V.
• Medtronic plc
• Monteris Medical Corporation
• Profound Medical Corp.
• Promaxo Inc. (neuro42, Inc.)
• Siemens AG
• Synaptive Medical
• Zimmer Biomet Holdings, Inc.
Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• U.K.
• Spain
• Rest-of-Europe
• Rest-of-the-World
• China
• Japan
• Rest-of-Rest-of-the-World
Read the full report: https://www.reportlinker.com/p06317751/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
